NCT03509675View on ClinicalTrials.gov

Use of Topical NSAID to Reduce Pain in Oral Lichen Planus and Oral Lichenoid Lesions.

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

April 29, 2018

Primary Completion Date

January 30, 2019

Study Completion Date

April 29, 2019

Conditions
Oral Lichen PlanusOral Lichenoid MucositisOral Lichenoid Reaction
Interventions
DRUG

Ibuprofen suspension 5mg/100ml

Non-Steroidal Anti-inflammatory Topical Rinse will be used for Symptomatic OLP patients.

DRUG

Placebos

Placebo

Trial Locations (1)

98195

University of Washington, Seattle

All Listed Sponsors
lead

University of Washington

OTHER

NCT03509675 - Use of Topical NSAID to Reduce Pain in Oral Lichen Planus and Oral Lichenoid Lesions. | Biotech Hunter | Biotech Hunter